In Washington, biotech's China hawks are winning the conversation
在华盛顿，生物技术领域的对华强硬派正占上风

Biopharma industry lobby groups working to keep the pipeline open for plentiful, lower-cost drugs coming from China have awakened to the fact that they face a vocal opposition and a growing set of anti-China proposals in Congress.
致力于维持来自manbetx3.0 的大量低成本药品“输美管道”畅通的生物制药行业游说团体，如今已经意识到，他们正面临着声音强烈的反对力量，以及国会中不断增多的反华提案。